Author:
Ding Jie,Zhao Jun,Chen Xing,You Zhiwen,Wang Haiyan
Abstract
Abstract
A 43-year-old man with chronic hepatitis B and elevated alpha-fetoprotein levels showed no malignant evidence on 18F-FDG PET/CT. However, subsequent assessment using 68Ga-FAPI-04 PET/MR identified a lesion with increased FAPI uptake in the liver, coupled with detailed enhancement patterns on MRI, leading to a diagnosis of hepatocellular carcinoma, later confirmed by pathology. This case highlights the pivotal role of integrated 68Ga-FAPI-04 PET and enhanced MRI in refining hepatocellular carcinoma diagnostics, advancing a more nuanced imaging approach over conventional modalities for comprehensive evaluation of hepatic lesions.
Publisher
Ovid Technologies (Wolters Kluwer Health)